Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06627374
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-26
Brief Title:
Study of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Predictive Value of Thoracic Ultrasound As a Response to the Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants an Observational Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LUNG PDA
Brief Summary:
The diagnostic hypothesis is based on the evidence that while the functional closure of the PDA Patent Ductus Arteriosus occurs within a few hours after birth anatomical closure may take several weeks The functional closure of the PDA can be extremely sensitive to variations in blood oxygen tension and the hemodynamic instability of preterm infants Therefore echocardiographic evaluation and ductal diameter at a single point in time such as during PDA echocardiography may not correlate with transductal blood flow Assessing the variation in the amount of pulmonary interstitial fluid using LUS lung ultrasound score could be an early predictive parameter for the closure or non-closure of hsPDA hemodynamically significant PDA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None